These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 11413918)

  • 1. [Is induction of oral tolerance to to insulin a suitable treatment concept in therapy of type I diabetes mellitus?].
    Marth T; Stallmach A
    Z Gastroenterol; 2001 May; 39(5):437-9. PubMed ID: 11413918
    [No Abstract]   [Full Text] [Related]  

  • 2. [Immune modulation therapy in type I diabetes mellitus].
    Schmeidl R; Teuber J; Paschke R; Schwedes U; Usadel KH
    Fortschr Med; 1986 Dec; 104(45):879-83. PubMed ID: 3542769
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immunoprevention of Type I diabetes mellitus].
    Spinas GA
    Ther Umsch; 1996 Dec; 53(12):882-8. PubMed ID: 9036566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration.
    Hutchings P; Cooke A
    J Autoimmun; 1998 Apr; 11(2):127-30. PubMed ID: 9650091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral administration of insulin to female nonobese diabetic mice inhibited diabetes and induced Fas ligand expression on islets of Langerhans.
    Wang H; Li Y; Sun Q; Yang G
    Chin Med J (Engl); 2000 May; 113(5):433-6. PubMed ID: 11776099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-specific tolerance in diabetes.
    Gottlieb PA; Eisenbarth GS
    Clin Immunol; 2002 Jan; 102(1):2-11. PubMed ID: 11781061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppression with cyclosporin induces clinical remission and improved beta cell function in patients with newly diagnosed insulin-dependent diabetes. A national and international multicenter study].
    Mandrup-Poulsen TR; Mølvig JC; Andersen V; Bendtzen K; Binder C; Brøns M; d'Amore FA; Dieperink H; Enk B; Frandsen NE
    Ugeskr Laeger; 1990 Jul; 152(27):1963-9. PubMed ID: 2195734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of oral insulin on the development of autoimmune diabetes in NOD mice fed a hypoallergenic diet.
    Shehadeh N; Weis R; Teninboum G; Benderly A; Etzioni A; Shamir R
    Diabetes Nutr Metab; 2004 Feb; 17(1):1-5. PubMed ID: 15163117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dendritic cell mediated therapy for immunoregulation of type 1 diabetes mellitus.
    Phillips BE; Giannoukakis N; Trucco M
    Pediatr Endocrinol Rev; 2008 Jun; 5(4):873-9. PubMed ID: 18552749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunogenetics and new therapies in type I diabetes mellitus].
    Gannage-Yared MH
    J Med Liban; 1999; 47(2):139-43. PubMed ID: 10410471
    [No Abstract]   [Full Text] [Related]  

  • 11. [Early diagnosis, early care--"Fr1da" screening of children for type 1 diabetes].
    Puff R; Haupt F; Winkler C; Assfalg R; Achenbach P; Ziegler AG
    MMW Fortschr Med; 2016 Mar; 158(4):65-6. PubMed ID: 27119891
    [No Abstract]   [Full Text] [Related]  

  • 12. No association of INS-VNTR genotype and IAA autoantibodies.
    Pérez de Nanclares G; Bilbao JR; Castano L
    Ann N Y Acad Sci; 2004 Dec; 1037():127-30. PubMed ID: 15699505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunosuppression in Type I diabetes mellitus].
    Schönle EJ; Sizonenko PC; Spinas GA
    Schweiz Rundsch Med Prax; 1990 Oct; 79(41):1225-7. PubMed ID: 2237051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunologic tolerance to intravenously injected insulin.
    Asai M; Yoshida M; Miura Y
    N Engl J Med; 2006 Jan; 354(3):307-9. PubMed ID: 16421379
    [No Abstract]   [Full Text] [Related]  

  • 15. Oral tolerance and autoimmune diabetes--will hope triumph over experience?
    Gale EA
    Lancet; 2000 Aug; 356(9229):526-7. PubMed ID: 10950225
    [No Abstract]   [Full Text] [Related]  

  • 16. Limited loss of tolerance to islet autoantigens in ICA+ first degree relatives of patients with type I diabetes expressing the HLA dqb1*0602 allele.
    Gianani R; Verge CF; Moromisato-Gianani RI; Yu L; Zhang YJ; Pugliese A; Eisenbarth GS
    J Autoimmun; 1996 Jun; 9(3):423-5. PubMed ID: 8816981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of cellular immunity in insulin-dependent diabetes mellitus (type 1)].
    Korfel J
    Pol Tyg Lek; 1985 May; 40(18):527-30. PubMed ID: 3892515
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of an artifical pancreas and portable pumps in the treatment of juvenile diabetes].
    Buysschaert M; Lambotte L; Lambert AE
    Journ Annu Diabetol Hotel Dieu; 1980 May; ():35-46. PubMed ID: 6995675
    [No Abstract]   [Full Text] [Related]  

  • 19. Preservation of C-peptide secretion in subjects at high risk of developing type 1 diabetes mellitus--a new surrogate measure of non-progression?
    Schatz D; Cuthbertson D; Atkinson M; Salzler MC; Winter W; Muir A; Silverstein J; Cook R; Maclaren N; She JX; Greenbaum C; Krischer J
    Pediatr Diabetes; 2004 Jun; 5(2):72-9. PubMed ID: 15189492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long term complications of IDDM and intensified insulin treatment.
    Misra A
    Natl Med J India; 1994; 7(4):174-5. PubMed ID: 7950951
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.